X0202 4 2008-03-18 0 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001363213 Blobel Friedhelm 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 1 1 0 0 President & CEO Non-Qualified Stock Option (right to buy) 1.81 2008-03-18 4 A 0 300000 0 A 2018-03-18 Common Stock 300000 300000 D Granted under the Issuer's 2005 Equity Incentive Plan. Provided Reporting Person remains employed by the Company, 50,000 shares will vest upon the Company's common stock trading publicly after March 17, 2008 for at least 30 consecutive calendar days at or greater than a target closing price per share as reported on the NASDAQ Global Market (a "Trading Price Goal"), of (a) $4.50 on or before June 2, 2009, (b) $6.00 on or before June 2, 2010, (c) $8.00 on or before June 2, 2011, (d) $10.00 on or before June 2, 2012, (e) $12.00 on or before June 2, 2013, and (f) $14.00 on or before June 2, 2014, each price as adjusted for stock dividends, stock splits or similar changes in the Company's capital structure. If a Trading Price Goal is not achieved on or before the respective target dates (06/02/2009, 06/02/2010, 06/02/2011, 06/02/2012, 06/02/2013 and 06/02/2014), the corresponding portion of the Option will not vest and will terminate upon such date. Friedhelm Blobel 2008-03-20